PAYCHEX INC quarterly report, Q3 FY2023

Paychex, Inc. Form 10-Q Summary

Business Context and Reporting Period

Paychex provides human capital management, payroll, HR, benefits, PEO, and insurance solutions primarily to small and midsized businesses in the United States and parts of Europe, with operations in India. The filing covers the three and nine months ended February 28, 2023, representing fiscal third quarter and year-to-date fiscal 2023 results. Comparisons are with the corresponding periods ended February 28, 2022.

Key Financial Metrics

MetricQ3 FY2023Q3 FY2022ChangeNine Months FY2023Nine Months FY2022
Total service revenue$1,345.7 million$1,261.6 million7%$3,702.6 million$3,424.4 million
Total revenue$1,381.0 million$1,276.0 million8%$3,777.5 million$3,467.4 million
Operating income$611.9 million$562.8 million9%$1,579.8 million$1,446.0 million
Net income$467.4 million$430.7 million9%$1,206.9 million$1,096.4 million
Diluted EPS$1.29$1.198%$3.33$3.02
Operating margin44.3%44.1%20 bps41.8%41.7%
Cash flow from operationsNot separately providedNot separately provided—$1,290.1 million$1,168.3 million

Management Solutions revenue increased 7% in the quarter and 9% year to date, driven by client and employee growth, higher revenue per client, increased product attachment, and continued ancillary-services growth. PEO and Insurance Solutions revenue increased 6% in both periods, supported by higher average worksite employees, wages, and state unemployment insurance revenue. Interest revenue on funds held for clients increased 144% in the quarter and 74% year to date, primarily because of higher average interest rates.

Adjusted net income was $466.7 million for the quarter and $1,198.0 million year to date, increases of 11% and 12%, respectively. Adjusted diluted EPS was $1.29 and $3.31, increases of 12% in both periods. EBITDA increased 7% to $655.8 million in the quarter and 7% to $1,714.1 million year to date. These are non-GAAP measures and should be evaluated alongside GAAP results.

Liquidity, Cash Flow, Debt, and Investments

  • Cash and cash equivalents were $1,316.9 million at February 28, 2023, compared with $370.0 million at May 31, 2022.
  • Total cash, restricted cash, and equivalents were $2,362.4 million at February 28, 2023, compared with $928.4 million at May 31, 2022.
  • Funds held for clients were $4,237.4 million, with related client fund obligations of $4,467.8 million. These balances fluctuate with the timing of client collections and payroll and tax remittances.
  • Corporate investments totaled $243.9 million, including current and long-term investments. Total short-term and long-term borrowings, net of debt issuance costs, were $808.3 million.
  • Credit facilities had $1,989.8 million of available capacity and $10.2 million outstanding at February 28, 2023. The $250 million PNC revolving facility was extended to February 6, 2026.
  • Long-term debt consisted primarily of $800.0 million of unsecured fixed-rate Senior Notes, with principal maturities in 2026 and 2029.
  • Year-to-date investing cash flow was positive $362.4 million, primarily because proceeds from sales and maturities of available-for-sale securities exceeded purchases. Dividends paid were $854.1 million, or $2.37 per share.
  • The investment portfolio had $230.5 million of net unrealized losses at February 28, 2023, compared with $136.3 million at May 31, 2022. Management attributed the losses primarily to interest-rate changes and reported no credit-loss impairment.

Material Changes Versus the Prior Comparable Period

  • Total revenue, operating income, and net income grew 8%, 9%, and 9%, respectively, in the third quarter.
  • Operating margin improved modestly from 44.1% to 44.3% in the quarter and from 41.7% to 41.8% year to date.
  • Expenses increased 8% in the quarter and 9% year to date. Compensation-related costs rose 9% and 11%, respectively, reflecting higher headcount and wage rates; other expenses rose 15% and 11%, respectively, due to business growth, marketing, and strategic initiatives.
  • The effective tax rate increased to 24.3% from 22.3% in the quarter, partly because the prior-year period benefited from a research-and-development tax benefit. The year-to-date rate was 23.8% versus 23.6%.
  • Cash flow from operations increased by $121.8 million year to date, while the change in cash, restricted cash, and equivalents improved to a $1,434.0 million increase from a $33.2 million decrease in the prior-year period.
  • The company had no share repurchases during the quarter. Of the $400 million repurchase authorization, $327.1 million remained available at February 28, 2023.

Outlook, Risks, Contingencies, and Unusual Items

Management stated that cash, restricted cash, corporate investments, projected operating cash flows, and available financing are expected to support operations, capital purchases, share repurchases, and dividends for the foreseeable future. The filing does not provide a specific revenue or earnings forecast in the supplied text.

  • Paychex identified risks involving cybersecurity, data privacy, technology and software performance, third-party providers, business continuity, PEO co-employment and insurance claims, client credit, regulatory changes, acquisitions, litigation, inflation, labor availability, and macroeconomic conditions affecting small and midsized businesses.
  • Workers’ compensation and health-insurance reserves depend on actuarial estimates and could change materially because of claim trends, legal developments, economic conditions, and settlement experience.
  • As of February 28, 2023, $3.2 billion of available-for-sale securities had fair values below amortized cost. Management stated that principal and interest were expected to be collected and that it did not intend, or expect to be required, to sell the investments before recovery or maturity.
  • A hypothetical 25-basis-point increase in longer-term interest rates was estimated to reduce the fair value of the available-for-sale portfolio by approximately $20 million to $25 million, with the effect generally recorded in stockholders’ equity unless credit impairment occurred.
  • Following the March 2023 failures of Silicon Valley Bank and Signature Bank, Paychex stated that it had no cash, restricted cash, or available-for-sale investments deposited with either institution and had met all client fund obligations.
  • Outstanding standby letters of credit totaled $141.7 million, primarily securing insurance commitments; none were drawn. Capital-asset purchase commitments totaled approximately $10.2 million, and remaining commitments to venture capital funds were approximately $8.1 million.
  • Management believed outstanding legal matters would not have a material adverse effect, while acknowledging that litigation outcomes are inherently uncertain.

Important Facts for Investors to Verify

  • Confirm the filing period: the report is for the quarter ended February 28, 2023, or fiscal Q3 2023, despite the request metadata referencing 2022 Q3.
  • Assess the sustainability of higher interest income as rates, investment balances, and portfolio reinvestment rates change.
  • Review the $230.5 million unrealized investment loss, portfolio duration, liquidity, and management’s ability to hold securities to recovery or maturity.
  • Evaluate client fund obligations separately from corporate liquidity because client funds are restricted and are not generally available for corporate purposes.
  • Monitor PEO insurance reserves, workers’ compensation and health claims, client credit exposure, and temporary-staffing receivables.
  • Reconcile GAAP earnings with adjusted net income, adjusted EPS, and EBITDA, and review the effect of prior-year tax benefits on comparisons.
  • Verify debt maturities, covenant compliance, available credit capacity, dividend commitments, and the status of the remaining share-repurchase authorization.